substance p and celecoxib
substance p has been researched along with celecoxib in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Salam, OM | 1 |
| Alves, DL; Caliari, MV; Duarte, ID; Francischi, JN; Maltos, KL; Menezes, GB; Rocha, OA; Santos, JM | 1 |
| Green, C; Hewlett, E; Hughes, M; Padgett, D; Schwartz, L; Tessier, J; Zhao, W | 1 |
| Balzarini, P; Bianchi, M; Broggini, M; Franchi, S; Sacerdote, P | 1 |
| Balla, K; Bendele, A; Bogseth, R; Gass, J; Graham, S; Hutchcraft, A; Rabinow, B; Valaitis, P; Werling, J | 1 |
| Hiller, JG; Ho, KM; Kuruvilla, N; Millen, R; Ramsay, R; Riedel, B; Sampurno, S | 1 |
Trials
2 trial(s) available for substance p and celecoxib
| Article | Year |
|---|---|
Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Celecoxib; Double-Blind Method; Female; Humans; Interleukin-6; Interleukin-8; Male; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Substance P; Sulfonamides; Synovial Fluid; Treatment Outcome | 2007 |
Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial.
Topics: Aged; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Neoplasms; Pain, Postoperative; Prospective Studies; Substance P | 2017 |
Other Studies
4 other study(ies) available for substance p and celecoxib
| Article | Year |
|---|---|
Modulation of inflammatory paw oedema by cysteamine in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Corticotropin-Releasing Hormone; Cystamine; Edema; Formaldehyde; Histamine; Indomethacin; Pyrazoles; Rats; Somatostatin; Substance P; Sulfonamides; Tumor Necrosis Factor-alpha | 2002 |
Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Calcitonin Gene-Related Peptide; Capillary Permeability; Celecoxib; Cyclooxygenase Inhibitors; Dental Pulp; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Leukocytes; Lipopolysaccharides; Male; Pulpitis; Pyrazoles; Rats; Skin; Substance P; Sulfonamides | 2004 |
Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis.
Topics: Animals; Antigens, Bacterial; Aprepitant; Bacillus anthracis; Bacterial Toxins; Capillary Permeability; Celecoxib; Cell Degranulation; Cell Line; Disease Models, Animal; Edema; Enzyme Inhibitors; Histamine; Histamine H1 Antagonists; Humans; Indomethacin; Injections, Intradermal; Mast Cells; Morpholines; Neurokinin-1 Receptor Antagonists; Prostaglandin Antagonists; Prostaglandins; Pyrazoles; Pyrilamine; Rabbits; Substance P; Sulfonamides; Tachykinins | 2007 |
Intra-articular (IA) ropivacaine microparticle suspensions reduce pain, inflammation, cytokine, and substance p levels significantly more than oral or IA celecoxib in a rat model of arthritis.
Topics: Administration, Oral; Amides; Animals; Arthritis, Experimental; Celecoxib; Cytokines; Inflammation; Injections, Intra-Articular; Male; Microspheres; Pain; Rats; Ropivacaine; Substance P | 2015 |